Cargando…
The role of the P2X7 receptor on bone loss in a mouse model of inflammation-mediated osteoporosis
In inflammatory autoimmune diseases, bone loss is frequent. In most cases, secondary osteoporosis is caused by treatment with systemic glucocorticoid. However, the pathogenesis behind the bone loss is presumed multifactorial. We aimed to elucidate the role of the P2X7 receptor on bone mineral densit...
Autores principales: | Kvist, T.M., Syberg, S., Petersen, S., Ding, M., Jørgensen, N.R., Schwarz, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736855/ https://www.ncbi.nlm.nih.gov/pubmed/29276731 http://dx.doi.org/10.1016/j.bonr.2015.09.003 |
Ejemplares similares
-
Association of P2X(7) receptor polymorphisms with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients
por: Wesselius, A., et al.
Publicado: (2012) -
The P2X7 Receptor: A Key Player in Immune-Mediated Bone Loss?
por: Kvist, Torben Madsen, et al.
Publicado: (2014) -
Association between P2X7 Receptor Polymorphisms and Bone Status in Mice
por: Syberg, Susanne, et al.
Publicado: (2012) -
P2X7 receptor regulates osteoclast function and bone loss in a mouse model of osteoporosis
por: Wang, Ning, et al.
Publicado: (2018) -
Genetic Background Strongly Influences the Bone Phenotype of P2X7 Receptor Knockout Mice
por: Syberg, Susanne, et al.
Publicado: (2012)